Associated Papers
Contribution of CYP19A1, CYP1A1, and CYP1A2 polymorphisms in coronary heart disease risk among the Chinese Han population.
Ye W et al.
Functional & Integrative Genomics, 2022
Review: Influence of the CYP450 Genetic Variation on the Treatment of Psychotic Disorders.
Carrascal-Laso L et al.
Journal of Clinical Medicine, 2021
Impact of CYP1A2 genetic polymorphisms on pharmacokinetics of antipsychotic drugs: a systematic review and meta-analysis.
Na Takuathung M et al.
Acta Psychiatrica Scandinavica, 2019
Influence of single-nucleotide polymorphisms on deferasirox C trough levels and effectiveness.
Cusato J et al.
The Pharmacogenomics Journal, 2015
Effect of CYP1A2 polymorphism on the pharmacokinetics of agomelatine in Chinese healthy male volunteers.
Song L et al.
Journal of Clinical Pharmacy and Therapeutics, 2014
Support for association of HSPG2 with tardive dyskinesia in Caucasian populations.
Greenbaum L et al.
The Pharmacogenomics Journal, 2012
Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia: systematic review and meta-analyses.
Fleeman N et al.
The Pharmacogenomics Journal, 2011
Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism.
Tiwari AK et al.
The Pharmacogenomics Journal, 2007
Ifcc Professional Scientific Exchange Programme (PSEP) Report: CYP1A2 And CYP3A4 Gene Polymorphisms.
Sáez PO
Ejifcc, 2005
A preliminary study of association of genetic variants with early response to olanzapine in schizophrenia.
Singh A et al.
Indian Journal of Psychiatry, 0
CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population.
Zhu Y et al.
Clinical Neuropharmacology, 0
Select a paper to view details